- Home
- NEUE vs LUCD Comparison
NEUE vs LUCD Comparison
Compare NEUE & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUE
- LUCD
- Stock Information
- Founded
- NEUE 2015
- LUCD 2018
- Country
- NEUE United States
- LUCD United States
- Employees
- NEUE N/A
- LUCD N/A
- Industry
- NEUE
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NEUE
- LUCD Health Care
- Exchange
- NEUE NYSE
- LUCD Nasdaq
- Market Cap
- NEUE 61.3M
- LUCD 112.5M
- IPO Year
- NEUE 2021
- LUCD 2021
- Fundamental
- Price
- NEUE $6.85
- LUCD $1.17
- Analyst Decision
- NEUE Hold
- LUCD Strong Buy
- Analyst Count
- NEUE 1
- LUCD 4
- Target Price
- NEUE $7.00
- LUCD $3.94
- AVG Volume (30 Days)
- NEUE 8.1K
- LUCD 1.5M
- Earning Date
- NEUE 08-06-2025
- LUCD 08-11-2025
- Dividend Yield
- NEUE N/A
- LUCD N/A
- EPS Growth
- NEUE N/A
- LUCD N/A
- EPS
- NEUE N/A
- LUCD N/A
- Revenue
- NEUE $907,349,000.00
- LUCD $4,173,000.00
- Revenue This Year
- NEUE $33.99
- LUCD $91.46
- Revenue Next Year
- NEUE $5.90
- LUCD $213.42
- P/E Ratio
- NEUE N/A
- LUCD N/A
- Revenue Growth
- NEUE N/A
- LUCD 39.89
- 52 Week Low
- NEUE $3.79
- LUCD $0.72
- 52 Week High
- NEUE $7.66
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- NEUE 52.49
- LUCD 48.87
- Support Level
- NEUE $6.75
- LUCD $1.00
- Resistance Level
- NEUE $6.91
- LUCD $1.23
- Average True Range (ATR)
- NEUE 0.08
- LUCD 0.07
- MACD
- NEUE -0.01
- LUCD 0.01
- Stochastic Oscillator
- NEUE 50.00
- LUCD 75.77
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.